Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
BIOMEDICAL PAPERS-OLOMOUC
ISSN 1213-8118 · eISSN 1804-7521 · Palacky University · CZECH REPUBLIC · Quarterly · Founded 1985
BIOMEDICAL PAPERS-OLOMOUC: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.8; fully open access; APC charged, amount not published; median 102 days to acceptance (41 articles, last 24 months); community-reported acceptance: easy; 33 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BIOMEDICAL PAPERS-OLOMOUC is published by Palacky University and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiovascular Function and Risk Factors, Adipokines, Inflammation, and Metabolic Diseases and Atrial Fibrillation Management and Outcomes, together about 17.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Biomedical Papers publishes reviews and original articles reporting on basic and clinical research in medicine. Articles in BIOMEDICAL PAPERS are published in English.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Jitka UlrichovPublisher website
Editorial board by country: none in mainland China; most named Czechia 6 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiovascular Function and Risk FactorsMedicine6.6%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.8%
- Atrial Fibrillation Management and OutcomesMedicine5.5%
- Heart Failure Treatment and ManagementMedicine5.3%
- Retinal Diseases and TreatmentsMedicine4.9%
- Cardiac pacing and defibrillation studiesMedicine4.7%
- Retinal and Macular SurgeryMedicine4.3%
- Cardiac Imaging and DiagnosticsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.8LetPub ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.53LetPub ·
- h-index
- 38LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 619OpenAlex ·
- 2-year mean citedness
- 0.84OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 33LetPub ·
Articles by year OpenAlex count · 1,572 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 31 | 1 |
| 2025 | 33 | 33 | 17 |
| 2024 | 43 | 43 | 72 |
| 2023 | 55 | 55 | 187 |
| 2022 | 49 | 49 | 246 |
| 2021 | 74 | 74 | 377 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 83 days – 133 days
- Acceptance to online
- median 17 days (40 articles)
- Submission to online
- median 127 days
- Sample
- 41 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CZK 13,000 / EUR 600 | No | CC BY | |
| OpenAlex | EUR 600 / CZK 13,000 | — | — | |
| Publisher website | EUR 600 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Plagiarism
- AI use POLICY ON THE USE OF GENERATIVE AI TOOLS
Policy on the use of generative AI tools. Model summary
The integration of artificial intelligence (AI) in academic writing has led to notable advantages, such as enhanced efficiency, higher linguistic quality, and more effective data analysis. At the same time, the use of AI in manuscript development demands transparency, ethical responsibility, and strict compliance with principles of academic integrity and including the recommendation of Committee o…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest statement
This information must be included in the manuscript before the References in this format: CONFLICT OF INTEREST STATEMENT: The authors state that there are no conflicts of interest regarding the publication of this article. If you have no declaration to make, please write: None declared. Up
Source ↗Publisher website ·- License & copyright COPYRIGHT NOTICE
Authors retain copyright and grant the journal right of first publication under a Creative Commons Attribution License. Model summary
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Open Access Statement This is an open access journal which means that …
Source ↗Publisher website ·- Open access
Open access journal. Model summary
This is an open access journal which means that all content is freely available without charge to the user or his/her institution.
Source ↗Publisher website ·- Plagiarism
All manuscripts are checked using iThenticate plagiarism detection software. Model summary
iThenticate plagiarism detection: All manuscripts submitted to Biomedical Papers (editorial system Actavia) are checked using the IThenticate software.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Palacky University
- Country or region
- CZECH REPUBLIC
- Language
- English
- Frequency
- Quarterly
- Founded
- 1985
- ISSN
- 1213-8118
- Electronic ISSN
- 1804-7521
- Latest issue on the website
- Volume 170 (2026)
- Official links
FAQ
Frequently asked questions about BIOMEDICAL PAPERS-OLOMOUC
What CAS zone is BIOMEDICAL PAPERS-OLOMOUC in?
In the 2025 upgraded edition of the CAS Journal Ranking, BIOMEDICAL PAPERS-OLOMOUC is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BIOMEDICAL PAPERS-OLOMOUC?
The latest impact factor listed by LetPub is 0.8; CiteScore 2.3, h-index 67.
How long does peer review take at BIOMEDICAL PAPERS-OLOMOUC?
Based on the dates recorded on 41 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 83–133 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of BIOMEDICAL PAPERS-OLOMOUC based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Czechia (6). Counted from the institutions listed on the board page; for reference only.
Which databases index BIOMEDICAL PAPERS-OLOMOUC?
According to LetPub and DOAJ records, BIOMEDICAL PAPERS-OLOMOUC is indexed in SCIE, Scopus and DOAJ.
Is BIOMEDICAL PAPERS-OLOMOUC open access, and what is the APC?
BIOMEDICAL PAPERS-OLOMOUC is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .